Developing guidelines for chronic kidney disease: We should include all of the outcomes

Annals of Internal Medicine

Volumn 156, Issue 8, 2012, Pages 599-601

  Uhlig, Katrin ^a   Levey, Andrew S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM;

EID: 84859762590     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-8-201204170-00012     Document Type: Editorial

References (22)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.[PMID: 11904577]
2. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67: 2089-100.[PMID: 15882252]
3. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379:165-80.[PMID: 21840587]
4. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-12.[PMID: 19414839]
5. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169-80. [PMID: 17660017]
6. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-69.[PMID: 14581387]
7. American Diabetes Association. Executive summary: standards of medical care in diabetes-2011. Diabetes Care. 2011;34 Suppl 1:S4-10.[PMID: 21193627]
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.[PMID: 12748199]
9. Hypertension: the clinical management of primary hypertension in adults. Clinical Guideline 127. Methods, evidence, and recommendations. August 2011. (Commissioned by the National Institute for Health and Clinical Excellence.) London: National Clinical Guideline Centre; 2011. Accessed at www.nice.org.uk /nicemedia/live/13561/56007/56007.pdf on 5 March 2012.
10. Brosius FC, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al; American Heart Association Kidney and Cardiovascular Disease Council. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation. 2006;114:1083-7. [PMID: 16894032]
11. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012;2:1-138.
12. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians clinical practice guideline. Ann Intern Med. 2012;156: 570-81.
13. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, et al. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment. Comparative Effectiveness Review no. 37. (Prepared by the Minnesota Evidence-based Practice Center under contract HHSA 290-2007-10064-I.) AHRQ Publication no. 11(12)-EHC075-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012. Accessed at www.effectivehealthcare.ahrq.gov/ehc /products/163/809/CER37-ChronicKidney_01-26-2012.pdf on 5 March 2012.
14. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D; U.S. Preventive Services Task Force. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med. 2007;147:871-5. [PMID: 18087058]
15. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1-290.[PMID: 15114537]
16. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008; 336:645-51. [PMID: 18299289]
17. Badve SV, Roberts MA, Hawley CM, Cass A, Garg AX, Krum H, et al. Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:1152-61.[PMID: 21884954]
18. Gandhi GY, Murad MH, Fujiyoshi A, Mullan RJ, Flynn DN, Elamin MB, et al. Patient-important outcomes in registered diabetes trials. JAMA. 2008;299: 2543-9.[PMID: 18523223]
19. Uhlig K, Boyd C. Guidelines for the older adult with CKD. Am J Kidney Dis. 2011;58:162-5.[PMID: 21664736]
20. Bowling CB, O'Hare AM. Managing older adults with CKD: individualized versus disease-based approaches. Am J Kidney Dis. 2012;59:293-302.[PMID: 22189037]
21. Jain AK, McLeod I, Huo C, Cuerden MS, Akbari A, Tonelli M, et al. When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int. 2009;76:318-23.[PMID: 19436331]
22. Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, et al; Alberta Kidney Disease Network. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA. 2010;303:1151-8.[PMID: 20332400]